
Inhaltsverzeichnis
Dasatinib induced pleural effusion and pulmonary hypertension. - Ponatinib induced stroke. - Nilotinib induced Peripheral Artery Occlusive Disease. - Imatinib cardiotoxicity. - Doxorubicin induced heart failure with reduced ejection fraction. - Trastuzumab-related cardiotoxicity. - Rituximab, Doxorubicin or cancer induced tachycardia. - Carfilzomib (CFZ) induced heart failure with reduced ejection fraction. - Immune checkpoint inhibitor cardiovascular toxicities. - Androgen deprivation therapy cardiotoxicity. - 5 FU induced atrial fibrillation in the context of ischemic heart disease. - Cisplatin induced acute coronary syndrome. - Radiotherapy and valvular heart disease. - Acute coronary syndrome in a patient with lung cancer 2 days after second cycle of carboplatin and Paclitaxel. - Ibrutinib and cardiac arrythmias. - Dual therapy BRAF inhibitor chemotherapy (dabrafenib +Trametinib chemotherapy) induced peripheral edema. - Vascular endothelial growth factor (VEGF) Bevacizumab and hypertension. - Amyloid heart disease. - Venous thromboembolism in cancer patients. - QT prolongation in cancer patients. - Cardiovascular implantable electronic devices (CIEDs)in cancer patients needs radiation therapy. - Atrial fibrillation in cancer patients. - Pericardial disease in cancer patients. - Large cardiac mass, an incidental finding in a patient with breast cancer.
Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Clinical Cases in Cardio-Oncology" und helfen Sie damit anderen bei der Kaufentscheidung.